The US Department of Justice asserted StarKist’s investment in TechPack Solutions, an India-based can and bottle technology firm, was worth more than the potential US$100 million fine StarKist faces for playing a part in a criminal price-fixing conspiracy.
StarKist’s own expert witness placed the value of StarKist’s holding in TechPack at US $155 million, and prosecutors said the holding gives StarKist “more than enough to pay for … the criminal fine and expected payouts in civil claims,” according to a summary of the June 12 hearing.
However, StarKist, which is pushing to have its criminal fine lowered to US$50 million, claimed it cannot sell its holding in TechPack due to loan agreements requiring the consent of its lenders. StarKist also argued selling its stake would be difficult.
As a result of the dispute, US District Court Judge Edward M. Chen postponed the sentencing hearing, in which he was to determine the amount of StarKist’s fine, until after a August 7 hearing on the TechPack issue.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas